. 2023 Feb 28;16(2):395–402. doi: 10.14202/vetworld.2023.395-402

Table-3.

In vitro digestibility.

Treatments	DMD (%)	OMD (%)
T0	63.40^a ± 1.78	64.36^a ± 2.08
T1	63.05^a ± 1.44	64.06^a ± 1.39
T2	63.89^a ± 2.04	64.98^a ± 2.28
T3	64.72^a ± 3.53	65.40^a ± 3.28
T4	70.29^d ± 0.53	71.16^cd ± 0.48
T5	65.65^b ± 0.91	67.28^ab ± 0.77
T6	67.64^bc ± 0.49	69.55^c ± 1.56
T7	64.08^a ± 3.03	65.73^a ± 3.34
T8	64.32^a ± 1.64	64.82^a ± 1.73
SEM	0.543	0.567

DMD=Dry matter digestibility, OMD=Organic matter digestibility, T0: Control (basal diet); T1: T0 + Lactobacillus parabuchneri strain 3347; T2: T0 + Lactobacillus buchneri strain 5296; T3: T0 + Lactobacillus harbinensis JCM 16178; T4: T0 + Schleiferilactobacillus harbinensis strain LH991; T5:T0 + Lactobacillus parabuchneri strain 6902; T6: T0 + Pichia kudriavzevii strain B-5P; T7: T0 + Pichia kudriavzevii strain CBS 5147; T8: T0 + commercial yeast (Saccharomyces cerevisiae). Superscripts ^{a, b, c, d, e} mean significantly different in a column (p<0.05). SEM=Standard error of the mean